Charter Research & Investment Group, Inc. Abbott Laboratories Transaction History
Charter Research & Investment Group, Inc.
- $126 Million
- Q1 2024
A detailed history of Charter Research & Investment Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Charter Research & Investment Group, Inc. holds 6,062 shares of ABT stock, worth $637,964. This represents 0.55% of its overall portfolio holdings.
Number of Shares
6,062
Previous 6,412
5.46%
Holding current value
$637,964
Previous $705,000
2.27%
% of portfolio
0.55%
Previous 0.59%
Shares
15 transactions
Others Institutions Holding ABT
# of Institutions
3,109Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.19M-
Vanguard Group Inc Valley Forge, PA165MShares$17.4 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$14 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.84 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.87 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.39 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $184B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...